Cardiology

Research supports pulmonary benefits for ACEIs, ARBs

(HealthDay)—Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) might play an important role in the prevention and treatment of emphysema, according to a study published in the May ...

Cardiology

ACE inhibitors, ARBs may slow percent emphysema progression

(HealthDay)—Use of angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) is associated with slowed progression of percent emphysema on chest computed tomography (CT), according to a study ...

Neuroscience

Drug combo slows heart decline in muscular dystrophy

Early use of available heart failure drugs slows the progressive decline in heart function before symptoms are apparent in boys and young men with Duchenne muscular dystrophy (DMD), according to a new study published online ...

page 7 from 14